Puma Biotechnology

PBYI • NASDAQ • Stock Fundamentals

Puma Biotechnology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alan H. Auerbach, with a market cap of $368.0M.

Market Cap$368.0M

Employees185.0

CEOAlan H. Auerbach

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Puma Biotechnology

Puma Biotechnology (PBYI) has a market capitalization of $368.0M and trades on NASDAQ.

Puma Biotechnology has approximately 185 employees.